These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36796864)

  • 1. Continuous quality improvement strategy for increasing immediate postpartum long-acting reversible contraceptive use at Jimma University Medical Center, Jimma, Ethiopia.
    Sori DA; Debelew GT; Degefa LS; Asefa Z
    BMJ Open Qual; 2023 Feb; 12(1):. PubMed ID: 36796864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of long-acting reversible contraceptive methods utilization and associated factors among counseled mothers in immediate postpartum period at Jimma University medical center, Ethiopia.
    Arero WD; Teka WG; Hebo HJ; Woyo T; Amare B
    Contracept Reprod Med; 2022 Sep; 7(1):17. PubMed ID: 36050794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of immediate post-partum long acting reversible contraceptives and its associated factors among mothers who gave birth in Addis Ababa public hospitals, Ethiopia: An institutional based cross-sectional study.
    Wudineh KG; Desalegn S; Ewunetu M; Shiferaw S
    PLoS One; 2023; 18(8):e0280167. PubMed ID: 37647331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and acceptability of a toolkit-based process to implement patient-centered, immediate postpartum long-acting reversible contraception services.
    Moniz MH; Dalton VK; Smith RD; Owens LE; Landis-Lewis Z; Peahl AF; Van Kainen B; Punch MR; Wetmore MK; Bonawitz K; Kolenic GE; Dehlendorf C; Heisler M
    Am J Obstet Gynecol; 2022 Mar; 226(3):394.e1-394.e16. PubMed ID: 34655551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statewide quality improvement initiative to implement immediate postpartum long-acting reversible contraception.
    Lacy MM; McMurtry Baird S; Scott TA; Barker B; Zite NB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S910.e1-S910.e8. PubMed ID: 31838123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process evaluation of postpartum contraceptive service delivery in Ayder Comprehensive Specialized Hospital Mekelle, Tigray, Ethiopia in 2020.
    Hagos KN; Gesese AA
    BMC Health Serv Res; 2023 Jul; 23(1):794. PubMed ID: 37533049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.
    Adeniyi OV; Ajayi AI; Somefun OD; Lambert JS
    Reprod Health; 2020 Dec; 17(1):194. PubMed ID: 33298097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico.
    Palm HC; Degnan JH; Biefeld SD; Reese AL; Espey E; Hofler LG
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S911.e1-S911.e7. PubMed ID: 31978431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
    Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
    Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
    Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum long-acting reversible contraceptives use in sub-Saharan Africa. Evidence from recent demographic and health surveys data.
    Asmamaw DB; Belachew TB; Fetene SM; Addis B; Amare T; Kidie AA; Endawkie A; Zegeye AF; Tamir TT; Wubante SM; Fentie EA; Negash WD
    PLoS One; 2023; 18(10):e0291571. PubMed ID: 37812616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informed choice and its associated factors among women received immediate postpartum long-acting reversible contraceptives at public hospitals in Sidama Regional State, Ethiopia, 2022.
    Samuel B; Tsegaye B; Dulla D; Aynalem A; Israel E; Gebrie M
    Contracept Reprod Med; 2023 May; 8(1):32. PubMed ID: 37165449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate versus delayed postpartum insertion of contraceptive implant for contraception.
    Sothornwit J; Werawatakul Y; Kaewrudee S; Lumbiganon P; Laopaiboon M
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011913. PubMed ID: 28432791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy change is not enough: engaging provider champions on immediate postpartum contraception.
    Okoroh EM; Kane DJ; Gee RE; Kieltyka L; Frederiksen BN; Baca KM; Rankin KM; Goodman DA; Kroelinger CD; Barfield WD
    Am J Obstet Gynecol; 2018 Jun; 218(6):590.e1-590.e7. PubMed ID: 29530670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significant influence of history of induced abortion on the utilisation of long-acting reversible contraceptive methods in the immediate post abortion period, Northern Ethiopia.
    Moges Mittiku Y; Tamiru AT; Rade BK
    Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):367-373. PubMed ID: 33860731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpartum long-acting reversible contraceptive use among active-duty, female US Army soldiers.
    Eastin EF; Nelson DA; Shaw JG; Shaw KA; Kurina LM
    Am J Obstet Gynecol; 2023 Oct; 229(4):432.e1-432.e12. PubMed ID: 37460035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.